Status:
ACTIVE_NOT_RECRUITING
Tele-rehabilitation Group Program for Urinary Incontinence in Older Women
Lead Sponsor:
Université de Montréal
Collaborating Sponsors:
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Réseau québécois de recherche sur le vieillissement (RQRV)
Conditions:
Urinary Incontinence
Urinary Stress Incontinence
Eligibility:
FEMALE
65+ years
Phase:
NA
Brief Summary
The recommended treatment for urinary incontinence (UI) in women is individualized pelvic floor muscle training (PFMT), a costly and resource-intensive approach; one Canada is currently unable to meet...
Eligibility Criteria
Inclusion
- 65 or older, as older women will show a particular genitourinary profile compared with younger women, notably due to menopause. This age cut-off was used in other studies in UI;
- Ambulatory (able to walk, move about safely and autonomously without any mobility device);
- Describe a pattern of stress/mixed UI, confirmed using the Questionnaire for Incontinence Diagnosis (QUID);
- Have at least three urinary leakage per week, persisting for 3 months or more;
- Understand French or English instructions;
- Report no important cognitive deficit (determined with a Mini-Mental State Evaluation (MMSE) score of 24/30 or more);
- Have an internet access; and
- Able to give informed consent and complete a gynecological examination and fill 7-day bladder diaries and questionnaires.
Exclusion
- Present risk factors known to interfere with the effects of PFMT or with the PFM evaluation, including chronic constipation (as defined by the International Working Committee for Chronic Constipation), important pelvic organ prolapse (Baden-Walker score \> stage 2), or any other comorbidities with a potential impact on the treatment (i.e. cognitive impairment, diabetes, active cancer, respiratory or cardiovascular conditions, etc);
- Currently taking medication for UI or medications affecting skeletal muscles;
- Considered obese with a body mass index (BMI) over 35;
- Had an active urinary or vaginal infection in the past 3 months;
- Underwent a change in hormonal replacement therapy in the past 6 months;
- Received pelvic floor physiotherapy treatment or surgery for UI or pelvic organ prolapse in the past year
Key Trial Info
Start Date :
March 6 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 6 2026
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05182632
Start Date
March 6 2021
End Date
April 6 2026
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de recherche de l'Institut universitaire de gériatrie de Montréal (CRIUGM)
Montreal, Quebec, Canada, H3W 1W4